Skip to main content
EPYSQLI 300 mg/30mL injection, solution by Teva Pharmaceuticals USA, Inc.
EPYSQLI, 300 mg/30mL, injection, solution Drug class: Complement Inhibitor. Available on prescription only. Listed by Teva Pharmaceuticals USA, Inc..
Prescription only

EPYSQLI

Eculizumab-aagh

Listed by Teva Pharmaceuticals USA, Inc.

Strength
300 mg/30mL
Form
Injection, Solution
Route
Intravenous
Class
Complement Inhibitor

What it contains

  • Eculizumab 300 mg/30mL

FDA record

Dosage form Injection, Solution
Route Intravenous
Drug class Complement Inhibitor
Approval route BLA — biologic licence
NDC code 51759-208
FDA application BLA761340
RxNorm concept 2706338
Package sizes listed 1
Marketed since April 2025

Other products containing Eculizumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

BKEMV

eculizumab-aeeb

Strength
300 mg/30mL
Form
Injection, Solution, Concentrate
Class
Complement Inhibitor
Rx only

Amgen Inc

Not stocked by us — reference only

SOLIRIS

ECULIZUMAB

Strength
300 mg/30mL
Form
Injection, Solution, Concentrate
Class
Complement Inhibitor
Rx only

Alexion Pharmaceuticals Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.